The La Jolla, California-based firm is moving beyond its US home market into other regions that promise growth for synthetic genomics providers.
A new study in Scientific Reports describes how scientists were able to replace an entire gene in a bacterial genome to study its function.
The deal covers SGI-DNA's line of DNA construct assembly kits, which are based on its Gibson Assembly DNA cloning approach, in North America and Europe.
SGI said this week that the Translational Research Institute, an Australian medical research and biopharmaceutical facility, has selected one of SGI's high-performance computing solutions to support its biomedical research efforts.
Japan's National Institute of Genetics has selected one of SGI's supercomputing systems to meet its next-generation sequence data analysis needs.
By Uduak Grace Thomas
French biotech firm Biogemma has deployed an informatics infrastructure based on GenomeQuest's analysis workflows and SGI's Altix UV 1000 platform.
The firms have partnered on developing high-performance computing solutions for agriculture genomics.
Genedata, Isilon, Entelos, SGI, IDBS
The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.
Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.
In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.
Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.